Hawking to promote Israeli ALS research

December 18, 2006 23:44
1 minute read.


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


Theoretical physicist Prof. Stephen Hawking, who has just completed a week-long visit to Israel, has volunteered to promote research into amyotrophic lateral sclerosis (motor neurone, or Lou Gehrig's disease) - from which he has suffered for 43 years - by the Israel ALS Research Association. IsrALS announced on Monday that the Cambridge University scientist has agreed to take part in its global campaign. The organization was founded three years ago by Haifa businessman David Cohen, who also has ALS. IsrALS focuses on research by Israeli scientists and the belief that they are capable of finding a cure. A number of high profile senior researchers have accepted the challenge and the fund-raising initiatives have begun. The ALS Project aims to raise awareness of the disease, encourage interest in the scientific community and raise money for research. The organization's third Israel Medical Conference on ALS Research will be held on Thursday at Tel Aviv's Dan Panorama Hotel. The move marks Hawking's recognition of a real opportunity for a scientific breakthrough by Israeli researchers. During his visit, he acknowledged Israel's lead in developing neurodegenerative drugs and in embryonic stem cell research, which could benefit ALS sufferers. IsrALS chief executive officer Nir Tsoran said, "We are very excited about Stephen Hawking's involvement in ALS and are confident that with his help, we will be able to promote the ALS Project to both domestic and international audiences. Although some 150 Israelis people die every year from the disease, it is largely neglected by pharmaceutical companies and the scientific community. Our aim is to change that, and with Stephen Hawking's help, we believe we can achieve our goal."

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia